IL2 and inflammatory bowel disease: To determine whether the 83 kb Il2 enhancer contributes to auto-inflammatory disease susceptibility in vivo, we used an adoptive transfer model of IBD in which the development of colitis is determined by the balance between conventional and regulatory CD4+ T cell activities (Powrie et al., 1994; Morawski et al., 2013).